KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gitlab (GTLB) Common Equity (2020 - 2026)

Gitlab (GTLB) has 7 years of Common Equity data on record, last reported at $990.7 million in Q1 2026.

  • On a quarterly basis, Common Equity rose 27.68% to $990.7 million in Q1 2026 year-over-year; TTM through Jan 2026 was $990.7 million, a 27.68% increase, with the full-year FY2026 number at $990.7 million, up 27.68% from a year prior.
  • Common Equity reached $990.7 million in Q1 2026 per GTLB's latest filing, up from $922.7 million in the prior quarter.
  • Over the last five years, Common Equity for GTLB hit a ceiling of $990.7 million in Q1 2026 and a floor of $593.2 million in Q4 2023.
  • A 5-year average of $788.4 million and a median of $814.7 million in 2022 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: skyrocketed 441.83% in 2022, then decreased 27.19% in 2023.
  • Tracing GTLB's Common Equity over 5 years: stood at $814.7 million in 2022, then dropped by 27.19% to $593.2 million in 2023, then grew by 27.69% to $757.4 million in 2024, then grew by 21.82% to $922.7 million in 2025, then increased by 7.36% to $990.7 million in 2026.
  • Business Quant data shows Common Equity for GTLB at $990.7 million in Q1 2026, $922.7 million in Q4 2025, and $911.6 million in Q3 2025.